| Literature DB >> 31410225 |
Negar Sharifi1, Anneh Mohammad Gharravi2.
Abstract
It is commonly accepted that the mechanical stimuli are important factors in the maintenance of normal structure and function of the articular cartilage. Despite extensive efforts, the cellular mechanisms underlying the responses of articular chondrocytes to mechanical stresses are not well understood. In the present review, different types of shear bioreactor and potential mechanisms that mediate and regulate the effect of shear on chondrocyte are discussed. For this review, the search of the literature was done in the PubMed, Scopus, Web of sciences databases to identify papers reporting data about shear on chondrocyte. Keywords "shear, chondrocyte, cartilage, bioreactor" were used. Studies published until the first of March 2018 were considered in this paper. The review focused on the experimental studies conducted the effect of shear stress on cartilage tissue in vivo and in vitro. In this review, both experimental studies referring to human and animal tissues were taken into account. The following articles were excluded: reviews, meta-analysis, duplicate records, letters, and papers that did not add significant information. Mechanism of shear stress on chondrocyte, briefly can be hypothesized as (1) altered expression of aggrecan and collagen type II, (2) altered cartilage oligomeric matrix protein (COMP) serum levels, consequently, organizing the arrangement binding of glycosaminoglycans, integrins, and collagen, (3) induction of apoptosis signals, (4) altered expression of integrin.Entities:
Keywords: Bioreactors; Chondrocyte; Regeneration; Shear
Year: 2019 PMID: 31410225 PMCID: PMC6686520 DOI: 10.1186/s41232-019-0105-1
Source DB: PubMed Journal: Inflamm Regen ISSN: 1880-8190
Fig 1.Flow chart illustrating the number of investigations and studies included in the analysis
Biochemical composition of hyaline articular cartilage [6, 7]
| Water | Collagens | Proteoglycans | Other molecules | |
|---|---|---|---|---|
| % | 70–80(per ww) | 50–75(per dw) | 15–30(per dw) | |
| Property | Interstitial fluid | Collagen type II | Aggrecan, (hyaluronan + chondroitin and keratan sulfates | Fibronectin, cartilage oligomeric protein, thrombospondin, tenascin, matrix-GLA (glycine-leucine-alanine) protein, chondrocalcin, and superficial zone protein |
| Function | Transporting both nutrients and waste within the tissue | Fibrillar and globular collagen types, such as types V, VI, IX, and XI Intermolecular interactions as well as modulating | Comprised of a protein core with attached polysaccharide chains (glycosaminoglycans). |
Zonal structure of hyaline articular cartilage: from the articulating surface down to the subchondral bone [6, 7]
| Zone | % | Collagen | Collagen alignment | Shape of cell | Proteoglycan | Property |
|---|---|---|---|---|---|---|
| The superficial (tangential) | 10–20 | Small diameter, densely packed collagen fibers | Parallel to the cartilage | Flattened, discoidal shapes | Low proteoglycan | Low permeability |
| The middle, or transitional | 40–60 | – | Arcade-like structure | Spherical in shape | Reaches its maximum | – |
| The deep zone/radial | 30% | Collagen large fibers | Perpendicular to the articular surface | Columnar organization. elongated | Proteoglycan much lower than in the middle zone | “Tidemark” |
| The calcified zone | – | – | – | – | – | transitions into the subchondral bone |
Territorial Structure of hyaline articular cartilage [8]
| Location | Collagen fibers | Proteoglycans | Function | |
|---|---|---|---|---|
| 1 | Pericellular matrix chondron | Type II, VI, and IX concentrated in the pericellular network of thin fibrils as fibronectin. | Mainly proteoglycans as aggrecan, hyaluronan and decorin, glycoproteins, and other non-collagenous proteins | Functional role to initiate signal transduction within cartilage with load bearing |
| 2 | (The territorial matrix) This region is thicker than the pericellular matrix | Fine collagen fibrils, forming a basketlike network around the cells Type VI collagen microfibrils but little or no fibrillar collagen. | High concentrations | May protect the cartilage cells against mechanical stresses and may contribute to the resiliency of the articular cartilage structure and its ability to withstand a substantial load |
The interterritorial matrix largest of the 3 matrix regions; it contributes most to the biomechanical properties of articular cartilage | Large collagen type IV fibers Randomly oriented bundles of large collagen fibrils, as zonal structure collagen type II, type XI collagen and type IX collagen | Are abundant | Bulk of articular cartilage permitting association with other matrix components and retention of proteoglycans. These collagens give to the cartilage form, tensile stiffness, and strength |
Properties of articular cartilage chondrocyte
| Chondrocyte | |
|---|---|
| Role | Development, maintenance, and repair of the extracellular matrix (ECM). |
| Origin | Mesenchymal stem cells |
| Volume | 2% of the total volume of articular cartilage. |
| Shape, number, and size | Vary in shape, number, and size, depending on the anatomical regions of the articular cartilage. |
| Respond to stimuli | Respond to a variety of mechanical stimuli and growth factors |
| Replication | Detectable cell division, limited potential for replication |
| Synthesis matrix | Responsible for both the synthesis and the breakdown of the cartilaginous matrix. |
| Differentiation | Highly differentiated cell, highly specialized, metabolically active cells |
| Adaption by low oxygen | Well adapted by low oxygen consumption to conditions |
Effect of experimental contact shear on chondrocyte proliferation and matrix composition
| Hz | % strain | Cell proliferation | Collagen | GAG | Proteoglycan | Scaffold | |
|---|---|---|---|---|---|---|---|
| [ | 1 | 2 | Chondrocyte | 40% increase | Not measured | 25% increase | (Cpp) calcium poly phosphate |
| [ | 0.01 | 0.4–1.6 | Chondrocyte | 40% increase | Not measured | 25% increase | Cartilage disk |
| [ | 0.1 | 0.5–6 | Chondrocyte | 30–35% increase | Not measured | 20–25% increase | Cartilage explant |
| [ | 0.0.1 | 1–3 | Chondrocyte | 50% increase | Not measured | 25% increase | Cartilage explant |
| [ | 0.05–0.5 | – | Chondrocyte | Not measured | Not measured | Not measured | Bovine nasal cartilage |
| [ | 1 | – | Chondrocyte | Not measured | Not measured | Not measured | Agarose |
| [ | 1 | 2.5% | Chondrocyte | Increase | Increase | Increase | Agarose gels |
| [ | 0.1 | 3 | Chondrocyte | 30–100% increase | Increase | 100–200% increase | Cartilage explant disks |
| [ | 0.5 | – | Chondrocyte | Not measured | Not measured | Not measured | No scaffolds |
| [ | 0.05 | – | Chondrocyte | Increase | Increase | Not measured | No scaffolds |
| [ | 0.5 | 10–20% | Chondrocyte | Increase | Increase | Increase | Fibrin-polyurethane |
Experimental fluid shear by different bioreactor and scaffolds and effects on chondrocyte proliferation and matrix composition
| RPM | Scaffold | Cell proliferation | Collagen | GAG | Proteoglycan | Type for bioreactor | |
|---|---|---|---|---|---|---|---|
| [ | 80 | PGA | Chondrocyte | Increase 80% | Increase | Not measured | Spinner flask |
| [ | 50 | PGA | Chondrocyte | Increase | Increase | Increase | Spinner flask |
| [ | 50 | No scaffolds | Chondrocyte | Increase 125% | Increase 60% | Not measured | Spinner flask |
| [ | 90 | osteochondral tissue | Chondrocyte | Increase | Increase | Increase | Spinner bioreactor |
| [ | 50–140 | No scaffolds | No cell | Not measured | Not measured | Not measured | Wavy-walled bioreactor |
| [ | – | chitosan/gelatin | Adipose-derived stem cells | Increase | Increase | Increase | Spinner flask |
| [ | – | No scaffolds | Chondrocyte | Not measured | Not measured | Not measured | 3D finite element model |
| [ | – | No scaffolds | No cell | Not measured | Not measured | Not measured | Hollow fiber (mathematical modeling) |
| [ | – | No scaffolds | Chondroprogenitor cells | Increase | Increase | Increase | Model |
| [ | – | No scaffolds | No cell | Not measured | Not measured | Not measured | Hollow fiber (mathematical modeling) |
Effect of perfusion bioreactor on chondrocyte proliferation and matrix composition
| Pa | Rate | Cell proliferation | Collagen | GAG | Proteoglycan | Scaffold | |
|---|---|---|---|---|---|---|---|
| [ | – | 0.33 ml/min | Chondrocyte | Collagen2 increase 240% | 300% (S)180% (NS) | Increase 35% aggrecan | Collagen sponges |
| [ | – | 1 μm/s | Chondrocyte | 155% increase | Increase 184% | Increase 118% | PLLA/PGA |
| [ | 0.01 | – | Chondrocyte | Increase | Increase | Increase | Micro-porous scaffolds |
| [ | 0.01 | 0.5 ml/min | Chondrocyte | Increase | Increase | Increase | Polyestherurethane foams |
| [ | 0.1. | 2 ml/min | Chondrocyte | Increase | Increase | Increase | Explant |
| [ | – | 0.1 ml/min | Human mesenchymal stem cells | Increase | Increase | Increase | Polycaprolactone (PCL) beads |
| [ | – | 3 ml/min | Chondrocyte | Increase | Increase | Increase | Alginate |
| [ | – | 0.33 ml/min | Chondrocyte | – | Increase | Increase | Electrospun poly(ε-caprolactone |
| [ | – | 1000, 300 μm/s | Chondrocyte | Increase | Increase | Increase | Collagen sponges |
| [ | 0.05–0.45 | 0.005–0.045 ml/min | Chondrocyte | Increase | Increase | Increase | Polyurethane |
| [ | – | 10 μm/s | Chondrocyte | Increase | Increase | Increase | No scaffolds |
Effect of perfusion bioreactor with low shear on chondrocyte proliferation and matrix composition
| Pa | RPM | Rate | Cell proliferation | Collagen | GAG | Proteoglycan | Scaffold | Bioreactor | |
|---|---|---|---|---|---|---|---|---|---|
| [ | 1.10 | – | 0.5–2 | Chondrocyte | Increase | Increase | Increase | Alginate | Perfusion |
| [ | – | 15–30 | – | Chondrocyte | Increase | Increase | Increase | Hyaluronan benzyl ester non-woven | Rotating |
| [ | – | – | – | No cell | Increase 33% | Increase 68% | Not measured | No scaffolds | Rotating |
| [ | – | – | – | Chondrocyte | Increase 39% | increase 95% | – | No scaffolds | - |
| [ | 17 kPa | 1.32 ml h−1 | Chondrocyte | Increase | Increase | Increase | Scaffold-free | acoustofluidic perfusion |